Tirzepatide — 10mg Ships from Ireland
Tracked shipping
Ireland1–2 working days
Europe5–10 working days
Research use only. This product is supplied strictly for in-vitro laboratory research. Not for human or veterinary use.
Research Peptide

Tirzepatide

Often studied for
Body weightAppetiteBlood sugar

Preparation: Freeze-dried powder — mixed with bacteriostatic water before research.

Tirzepatide is studied for how it works with two of the body's natural signals at once — rather than just one, like most earlier compounds. It's been tested in a large number of human trials, making it one of the most well-documented peptides of its kind. Supplied as a freeze-dried powder for laboratory research use only.

1
Preparation Essentials
Bacteriostatic Water
Bacteriostatic Water

Commonly used to prepare freeze-dried peptide products.

20
In stock
Research Starter Pack
Research Starter Pack

Five 1 ml syringes with preparation wipes

5
In stock

Preparation

Supplied as a freeze-dried powder and commonly prepared using bacteriostatic water before research. Add the water slowly, then swirl gently — don't shake — until fully dissolved. Keep the mixed solution in the fridge; we'll confirm the exact stability window shortly.
Need help calculating the volume? Open Reconstitution Calculator

Related Compounds

Research Information

Everything below summarizes the current published research on this compound.

What Is Tirzepatide?

Tirzepatide is an investigational peptide currently being studied for body weight, appetite and blood sugar in laboratory research. It is supplied as a freeze-dried powder for laboratory and research use only.

Why Is It Being Researched?

Researchers want to know what happens when two of the body's natural appetite and blood sugar signals are engaged together, rather than one at a time. It's a central question in current research: does combining signals change the results compared to using just one?

Common Research Areas

  • Body weight
  • Appetite
  • Blood sugar

In scientific terms, tirzepatide is a "dual agonist" that interacts with two hormone receptors — GIP and GLP-1. It's been tested in a large programme of human trials — reportedly ten Phase 3 studies with more than 13,000 people — looking at blood sugar and body weight. These are results from controlled trials, not a prediction for any one person.

Frequently Asked Questions

What's different about tirzepatide compared to semaglutide?

Semaglutide works with one signal (GLP-1). Tirzepatide works with two (GIP and GLP-1) at once. Researchers compare the two to understand whether using both signals together changes the results.

What's different about tirzepatide compared to retatrutide?

Tirzepatide uses two signals; retatrutide adds a third. Comparing the two is a major focus of current research.

Why don't you have full specifications listed yet?

We only publish numbers once we've checked them against our supplier's own results certificate. We'd rather be upfront about a short delay than post a number before we're sure it's right.

For research use only.

Our products are supplied for laboratory and in-vitro research and are not intended for human or veterinary use. By ordering, you confirm you're a qualified researcher and will handle the material responsibly.